Bispep 87.5 mg/5 ml (Oral Suspension)
Medicine Details
| Category | Details |
|---|---|
| Generic | Bismuth subsalicylate |
| Company | Benham pharmaceuticals ltd |
Indications
- upset stomach
- indigestion
- heartburn
- nausea
- diarrhea
Pharmacology
- antacid action
- anti-diarrheal action
- anti-inflammatory action
- coats ulcer surface
- stimulates mucus secretion
- bicarbonate secretion
- disrupts cell
- reduces inflammation
Dosage & Administration
- Adult (>16): 30 ml in dosing cup provided or 6x5 ml spoonful
- Children (10-14 years): 15 mL (3 teaspoons)
- Children (5-9 years): 7.5 mL (1.5 teaspoons)
- Children (3-4 years): 5 mL (1 teaspoon)
- Children under 3 years: Ask a doctor
- Use in the elderly: No special precaution is needed
- Patient is suffering from renal insufficiency: caution should be taken
- Repeat dose: every ½ to 1 hour if needed. Not more than 8 doses to be taken in 24 hours
Interaction
Contains salicylates therefore care should be exercised if receiving drugs to thin the blood (anticoagulant therapy) or oral therapy for diabetes or treatment for gout or arthritis
Contraindications
Should not be used by patients hypersensitive to Aspirin or other salicylates or any ingredient in this formulation. Keep all medicines out of reach and sight of children
Side Effects
- Black stool
- black tongue
Pregnancy & Lactation
There are no adequate data concerning the use of Bismuth Subsalicylate in pregnant women. Animal studies are insufficient with respect to effects on pregnancy, embryonal/foetal development, parturition and postnatal development. The potential risk for humans is unknown. Bismuth Subsalicylate should not be used during lactation unless clearly necessary
Precautions & Warnings
Do not take with aspirin or other salicylates. Caution should be exercised by patients taking medicines for anti-coagulation (thinning of the blood), diabetes or gout
Overdose Effects
Bispep intoxication may present as an acute encephalopathy with confusion, myoclonic movements, tremor, dysarthria and walking and standing disorders. Bispep intoxication may also cause gastrointestinal disturbances, skin reactions, discoloration of mucous membranes, and renal dysfunction as a result of acute tubular necrosis. Treatment includes gastric lavage, purgation and hydration. Chelating agents may be effective in the early stages following ingestion and haemodialysis may be necessary. Overdose of Bispep may also give symptoms of salicylate intoxification e.g. dizziness, tinnitus, sweating, nausea, headache. If symptoms occur, use of Bispep should be discontinued. Management of overdose is the same as that for salicylate overdose
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children